Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfoliosEvents
    Companies/DCOY

    Decoy Therapeutics Inc.(DCOY)

    Biotechnology
    Infectious Disease Biotech
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    50.0
    Insider Trading Score
    Peer Group Scores
    REGN
    74    VRTX
    65    PFE
    65    MRNA
    54    DCOY
    50    SNGX
    50    XBIT
    50    BIIB
    50    ARCT
    50    ARVN
    42    GILD
    37
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeShares ownedAvg. PriceValueFiling
    2026-01-02
    HANISH ARNOLD C
    Director
    Sale
    		-27
    -0.32%8,293
    		$0.64$17View SEC filing
    2025-11-24
    HANISH ARNOLD C
    Director
    Purchase
    		+5,000
    +150.60%8,320
    		$0.75$3,741View SEC filing
    2025-11-20
    Rosenblum Mark J
    Exec VP Finance, CFO
    Purchase
    		+20,000
    +369.21%25,417
    		$0.80$16,000View SEC filing
    2022-06-08
    Burleson Tess
    Director
    Purchase
    		+27,700
    +636.78%32,050
    		$0.18$4,986View SEC filing
    2022-06-08
    Lieber Jonathan I
    Director
    Purchase
    		+37,500
    +100.00%37,500
    		$0.19$7,016View SEC filing
    2022-06-07
    McVicar William K.
    Director
    Purchase
    		+26,553
    +100.00%26,553
    		$0.19$5,000View SEC filing
    2022-06-06
    HANISH ARNOLD C
    Director
    Purchase
    		+28,000
    +152.59%46,350
    		$0.18$5,152View SEC filing
    2022-06-06
    HANISH ARNOLD C
    Director
    Purchase
    		+4,000
    +54.42%11,350
    		$0.98$3,920View SEC filing
    2022-06-06
    HANISH ARNOLD C
    Director
    Purchase
    		+4,350
    +145.00%7,350
    		$1.15$5,003View SEC filing
    2022-06-06
    HANISH ARNOLD C
    Director
    Purchase
    		+3,000
    +100.00%3,000
    		$3.59$10,770View SEC filing
    2022-05-31
    Arthur David J.
    Chief Executive Officer
    Purchase
    		+43,900
    +5.26%878,022
    		$0.18$7,985View SEC filing
    2022-05-31
    Rosenblum Mark J
    Exec VP Finance, CFO
    Purchase
    		+28,000
    +23.27%148,319
    		$0.18$5,040View SEC filing
    2022-03-09
    Rosenblum Mark J
    Exec VP Finance, CFO
    Purchase
    		+76,246
    +223.77%110,319
    		$0.39$29,812View SEC filing
    2022-03-09
    Arthur David J.
    Chief Executive Officer
    Purchase
    		+139,488
    +126.59%249,674
    		$0.39$54,540View SEC filing
    2021-08-17
    Arthur David J.
    Chief Executive Officer
    Purchase
    		+4,000
    +2.02%202,494
    		$0.90$3,582View SEC filing
    2021-08-11
    HANISH ARNOLD C
    Director
    Purchase
    		+7,000
    +61.67%18,350
    		$0.88$6,167View SEC filing
    2020-08-24
    HANISH ARNOLD C
    Director
    Purchase
    		+4,000
    +54.42%11,350
    		$0.98$3,920View SEC filing
    2020-08-20
    Arthur David J.
    Chief Executive Officer
    Purchase
    		+2,000
    +200.00%3,000
    		$1.01$2,020View SEC filing
    2020-08-18
    Rosenblum Mark J
    Exec VP Finance, CFO
    Purchase
    		+5,000
    +71.43%12,000
    		$1.00$5,000View SEC filing
    2020-02-20
    Rosenblum Mark J
    Exec VP Finance, CFO
    Purchase
    		+2,000
    +40.00%7,000
    		$0.95$1,900View SEC filing
    2020-02-18
    Jordan Scott
    Chief Business Officer
    Purchase
    		+11,300
    +55.64%31,609
    		$0.90$10,170View SEC filing
    2020-02-13
    Rosenblum Mark J
    Exec VP Finance, CFO
    Purchase
    		+5,000
    +100.00%5,000
    		$0.86$4,295View SEC filing
    2020-02-13
    Arthur David J.
    Chief Executive Officer
    Purchase
    		+2,175
    +100.00%2,175
    		$0.01$22View SEC filing
    2020-02-13
    Northrup Jonathan P
    Director
    Purchase
    		+8,700
    +100.00%8,700
    		$0.01$87View SEC filing
    2020-02-13
    Burleson Tess
    Director
    Purchase
    		+4,350
    +100.00%4,350
    		$0.01$44View SEC filing

    1-25 of 109

    Page 1 of 5